Precision BioSciences, Inc. announced that Alex Kelly has been appointed to the newly created position of Chief Corporate Affairs Officer. In this role, Alex joins the senior leadership team, reporting to Matt Kane, Chief Executive Officer at Precision and will oversee all investor relations and corporate communications. Alex joins Precision BioSciences from Allergan, where he was Executive Vice President, Corporate Affairs and Chief Communications Officer and President of The Allergan Foundation. In these roles, Alex developed internal and external messaging that shaped the company culture and supported several successful company transformations including the recent merger with AbbVie. Alex also had a very active role in shaping Allergan’s Social Contract with Patients, the first commitment by a large biopharma company to provide accessible and affordable medicines. Previously, Alex served as Senior Vice President, Chief Integration Officer for Actavis where he led back-to-back integration efforts for both the acquisition of Forest Labs (in 2014) and Allergan (in 2015).